Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation-Reference-Cited by-全球学者库

Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation

Published:2020-02-14 Issue:7 Volume:7 Page:1903138
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Lin Liteng¹^ORCID,Gong Hengye²,Li Rui¹,Huang Jingjun¹,Cai Mingyue¹,Lan Tian³,Huang Wensou¹,Guo Yongjian¹,Zhou Zhimei¹,An Yongcheng¹,Chen Zhiwei¹,Liang Licong¹,Wang Yong⁴,Shuai Xintao²^ORCID,Zhu Kangshun¹^ORCID

Affiliation:

1. Laboratory of Interventional RadiologyDepartment of Minimally Invasive Interventional Radiology and Department of RadiologyThe Second Affiliated Hospital of Guangzhou Medical University Guangzhou 510260 China

2. PCFM Lab of Ministry of EducationSchool of Material Science and EngineeringSun Yat‐Sen University Guangzhou 510275 China

3. School of PharmacyGuangdong Pharmaceutical University Guangzhou 510006 China

4. College of Chemistry and Materials ScienceJinan University Guangzhou 510632 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.201903138

Reference65 articles.

1. Mechanisms of fibrosis: therapeutic translation for fibrotic disease

2. Mechanisms of hepatic fibrogenesis

3. Liver cirrhosis

4. Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis

5. Hepatic inflammation and fibrosis: Functional links and key pathways

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy;Acta Biomaterialia;2024-02

2. Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents;Journal of Materials Chemistry B;2024

3. Mesenchymal Stem Cell–Derived Exosomes in Various Chronic Liver Diseases: Hype or Hope?;Journal of Inflammation Research;2024-01

4. Remodeling of the liver fibrosis microenvironment based on nilotinib-loaded multicatalytic nanozymes with boosted antifibrogenic activity;Acta Pharmaceutica Sinica B;2023-12

5. Hepatic Stellate Cell- and Liver Microbiome-Specific Delivery System for Dihydrotanshinone I to Ameliorate Liver Fibrosis;ACS Nano;2023-11-23